Ivy Rx Review
Best for: mainstream telehealth GLP-1 access
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Ivy Rx is a solid telehealth option with balanced features and pricing.
Ivy Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $175/mo (Range up to $197/mo)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Ivy Rx
Each dimension is scored algorithmically from Ivy Rx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.7/10At $175/mo, Ivy Rx runs in line with the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Ivy Rx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
8.1/10Ivy Rx treats patients in all 50 states.
Support10%
5.7/10Ivy Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Ivy Rx review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Ivy Rx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Range up to $197/mo
Range up to $297/mo
Ready to get started?
Plans and promotions change often — check Ivy Rx's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Ivy Rx: a flat-rate compounded GLP-1 shop with a simple promise
Ivy Rx is a no-frills telehealth provider built around one idea that most patients actually care about: you pay the same price no matter how high your dose climbs. Where a lot of GLP-1 programs quietly raise your bill every time your prescriber bumps your milligrams, Ivy Rx markets a flat rate — "same price, every dose, no surprises, no insurance needed." If you found GLP-1 medication confusing or you got burned by a program that escalated costs as you titrated up, Ivy Rx is worth a look. Just go in knowing it publishes relatively little about its operation, which is the main reason to keep your expectations measured.
How the flat pricing really works
Ivy Rx runs two straightforward programs. Compounded semaglutide starts at $175 a month, and compounded tirzepatide starts higher, in the high-two-hundreds. The word "starting" matters: the published ranges drift up modestly from there (semaglutide into the high-one-nineties, tirzepatide into the high-two-nineties), so the flat-rate promise is best understood as a tight band rather than a single frozen number. The important part is that the band is driven by which medication you're on, not by how far you titrate. Once you're on semaglutide, going from a low maintenance dose to a higher one shouldn't change your monthly cost the way it does at dose-tiered competitors.
For context, Ivy Rx's entry semaglutide price sits a touch above the category median of $170 a month — so it isn't the rock-bottom cheapest option, but it's firmly in mainstream territory and undercuts the thousand-dollar-plus list prices of brand-name injectables by a wide margin.
What's bundled into the price
- The medication itself
- The medical consultation and prescriber approval
- Shipping to your door, advertised as fast and free
That bundle matters because some "cheap" programs tack on a separate consult fee or charge for shipping. Ivy Rx folds all three into the monthly number, so the price you see is closer to the price you actually pay. There's no membership add-on stacked on top that we could find.
The medications and how you get them
Both of Ivy Rx's drugs are compounded — not the brand-name Wegovy, Ozempic, Zepbound, or Mounjaro you'd get at a retail pharmacy, but versions of the same active ingredients (semaglutide and tirzepatide) made by a compounding pharmacy. Compounded GLP-1s are typically less expensive and have been a workaround during brand shortages, but they aren't FDA-approved products and quality hinges entirely on the pharmacy behind them. Ivy Rx advertises a free consultation with fast approval and quick delivery, which points to a streamlined, asynchronous online intake rather than a high-touch clinical relationship.
What sets Ivy Rx apart — and what's missing
The genuine differentiator here is dose-independent pricing on two of the most-wanted GLP-1 molecules at once. Plenty of providers carry semaglutide; fewer pair it with tirzepatide and then commit to not punishing you for titrating up. If predictable monthly budgeting is your priority, that's a real selling point.
The honest flip side is transparency. Ivy Rx publishes limited detail about the nuts and bolts of its program. We could not verify which compounding pharmacy fills its prescriptions, what accreditation that pharmacy holds, or its concrete policies on refunds, dose changes, side-effect support, or what happens if you pause treatment. Its nationwide availability is listed as all fifty states, but that figure still needs independent confirmation. None of that is a red flag on its own — it's simply unverified, and for a medication you inject weekly, unverified is a fair reason to ask questions before you pay.
Who should choose Ivy Rx — and who should skip it
- Good fit: budget-minded patients who want a predictable, flat monthly cost as they titrate, and who are comfortable with compounded medication and a low-touch online process
- Good fit: people who want both semaglutide and tirzepatide available from one provider without dose-based price creep
- Skip it if: you want brand-name Wegovy or Zepbound — Ivy Rx only offers compounded formulations
- Skip it if: you need hands-on clinical support, detailed published policies, or a named, accredited pharmacy you can vet before committing
Trust, safety, and medical oversight
On the reassuring side, Ivy Rx has no FDA warning letters on file with us, and its programs include a prescriber consultation rather than selling medication with no clinical gate. On the cautious side, our verification confidence is limited by how little the provider discloses: with no identified compounding partner and no published accreditation, you're taking the support model partly on faith. The pragmatic move is to confirm the pharmacy's name and accreditation, the current exact price for your specific drug, and the refund and dose-change terms directly with Ivy Rx before your first order. You can see how we weigh these factors in our scoring methodology.
The bottom line
Ivy Rx is a clean, mainstream way to get compounded semaglutide or tirzepatide at a flat rate that won't balloon as your dose rises, with the consult and shipping baked in. That predictability is its strongest card. The catch is thin public information — so it earns a qualified recommendation for cost-conscious patients who are comfortable doing a little homework on the phone before they buy, rather than for anyone who needs everything spelled out and accredited up front.
For a side-by-side, Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are the most comparable options to weigh against Ivy Rx.
Ready to start with Ivy Rx?
Starting at $175/month. See current pricing and start your free consultation.
Alternatives to Ivy Rx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ivy Rx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Ivy Rx?
Starting at $175/month. See current pricing and start your free consultation.